{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:14:14Z","timestamp":1788383654932,"version":"build-2803163510"},"reference-count":34,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Cancer"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n In recent years, the global incidence of thyroid cancer has been increasing.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aimed to examine the association between Hashimoto thyroiditis (HT) and papillary thyroid cancer (PTC) progression under active surveillance (AS).<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Our retrospective study was conducted at Peking University Third Hospital and included 203 patients with PTC who underwent AS for \u22656 months before surgery. Patients were first categorized into 2 groups: the HT group (n=90) and the non-HT group (n=113). Cox proportional hazards models were then used to evaluate the association between HT and PTC progression during AS, adjusting for age, sex, baseline tumor size, BMI, pregnancy status, number of tumor foci, and thyroid-stimulating hormone level. Subgroup analyses stratified by the 6 covariates mentioned above were also applied to explore the potential effect modification.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n No significant difference was observed between the HT and non-HT groups in PTC progression-free survival (hazard ratio [HR] 1.11, 95% CI 0.61\u20101.99;\n P<\/jats:italic>\n =.74), tumor enlargement-free survival (HR 1.02, 95% CI 0.56\u20101.86;\n P<\/jats:italic>\n =.95), or lymph node metastasis-free survival (HR 1.76, 95% CI 0.31\u201010.12;\n P<\/jats:italic>\n =.52). Subgroup analyses revealed a potential interaction between HT and BMI. Among patients who were overweight or obese (BMI >24 kg\/m\u00b2), HT was significantly associated with an increased risk of disease progression (HR 6.32, 95% CI 1.84\u201021.69;\n P<\/jats:italic>\n =.003), while among patients with BMI \u226424 kg\/m\n 2<\/jats:sup>\n , no association between HT and progression risk was observed (\n P<\/jats:italic>\n =.01).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n We found no evidence of association between HT and PTC progression during AS. However, the relationship between HT and PTC progression may be modified by overweight or obesity status.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/80535","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T21:51:08Z","timestamp":1767736268000},"page":"e80535-e80535","source":"Crossref","is-referenced-by-count":1,"title":["Hashimoto Thyroiditis and Progression of Papillary Thyroid Cancer: 10-Year Retrospective Cohort Study"],"prefix":"10.2196","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9475-4611","authenticated-orcid":false,"given":"Xin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9073-0418","authenticated-orcid":false,"given":"Xiangyun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7603-337X","authenticated-orcid":false,"given":"Rui","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5690-674X","authenticated-orcid":false,"given":"Fang","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6981-1142","authenticated-orcid":false,"given":"Shibing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6452-9082","authenticated-orcid":false,"given":"Bangkai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1344-6004","authenticated-orcid":false,"given":"Chunhui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0405-2348","authenticated-orcid":false,"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"6","key":"R1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.8759","article-title":"Global burden of thyroid cancer from 1990 to 2017","volume":"3","author":"Deng","journal-title":"JAMA Netw Open"},{"issue":"4","key":"R2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020","volume":"10","author":"Pizzato","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"R3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28054","article-title":"Hashimoto's thyroiditis effects on papillary thyroid carcinoma outcomes: a systematic review","volume":"14","author":"Osborne","journal-title":"Cureus"},{"issue":"1","key":"R4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12020-020-02207-6","article-title":"Thyroid cancer: incidence and mortality trends in China, 2005-2015","volume":"68","author":"Wang","journal-title":"Endocrine"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","journal-title":"J Natl Cancer Cent"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.03.027","article-title":"Epigenetic regulation of papillary thyroid carcinoma by long non-coding RNAs","volume":"83","author":"Lin","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"R7","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jamaoto.2017.1442","article-title":"Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance","volume":"143","author":"Tuttle","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"2","key":"R8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1210\/jc.2017-01775","article-title":"High serum TSH level is associated with progression of papillary thyroid microcarcinoma during active surveillance","volume":"103","author":"Kim","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","journal-title":"Thyroid"},{"issue":"3","key":"R10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3760\/cma.j.cn311282-20221023-00589","article-title":"Guidelines for the diagnosis and management of thyroid nodules and differentiated thyroid cancer (Second edition)","volume":"39","author":"Endocrinology Branch of the Chinese Medical Association, Thyroid and Metabolic Surgery Group, Surgery Branch of Chinese Medical Association, Head and Neck Tumor Professional Committee of the Chinese Anti-Cancer Association, Nuclear Medicine Branch of the Chinese Medical Association, Thyroid Cancer Professional Committee of the Chinese Anti-Cancer Association, Thyroid Surgeon Committee of the Surgeon Branch of the Chinese Medical Doctor Association, Ultrasound Medicine Branch of the Chinese Medical Association","journal-title":"Chin J Endocrinol Metab"},{"key":"R11","unstructured":"NCCN clinical practice guidelines in oncology-thyroid carcinoma (version 1). National Comprehensive Cancer Network. 2025. URL: https:\/\/www.nccn.org\/guidelines\/category_1 [Accessed 15-12-2025]"},{"key":"R12","unstructured":"Kaur J Jialal I . Hashimoto thyroiditis. In: StatPearls. StatPearls Publishing; 2024. URL: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459262\/ [Accessed 18-12-2025] [Medline: 29083758]"},{"issue":"3","key":"R13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1530\/EJE-12-0903","article-title":"The association between papillary thyroid carcinoma and histologically proven Hashimoto\u2019s thyroiditis: a meta-analysis","volume":"168","author":"Lee","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"R14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18526","article-title":"Prevalence of Hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes","volume":"4","author":"Xu","journal-title":"JAMA Netw Open"},{"issue":"2","key":"R15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/thy.2012.0554","article-title":"Hashimoto\u2019s thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records","volume":"23","author":"Caturegli","journal-title":"Thyroid"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.801925","article-title":"Hashimoto's thyroiditis: a \u201cdouble-edged sword\u201d in thyroid carcinoma","volume":"13","author":"Xu","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"R17","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230006","article-title":"US predictors of papillary thyroid microcarcinoma progression at active surveillance","volume":"309","author":"Lee","journal-title":"Radiology"},{"issue":"6","key":"R18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/jamaoto.2020.0368","article-title":"Association of patient age with progression of low-risk papillary thyroid carcinoma under active surveillance: a systematic review and meta-analysis","volume":"146","author":"Koshkina","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"11","key":"R19","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1089\/thy.2021.0614","article-title":"Progression of low-risk papillary thyroid microcarcinoma during active surveillance: interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma in Korea","volume":"32","author":"Lee","journal-title":"Thyroid"},{"issue":"3","key":"R20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1210\/clinem\/dgad557","article-title":"Pregnancy and progression of differentiated thyroid cancer: a propensity score-matched retrospective cohort study","volume":"109","author":"Xiao","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1089\/thy.2015.0313","article-title":"Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery","volume":"26","author":"Oda","journal-title":"Thyroid"},{"issue":"11","key":"R22","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1089\/jwh.2023.0172","article-title":"The association of pregnancy with disease progression in patients previously treated for differentiated thyroid cancer: a propensity score-matched retrospective cohort study","volume":"32","author":"Li","journal-title":"J Womens Health (Larchmt)"},{"issue":"8","key":"R23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","journal-title":"Thyroid"},{"issue":"5","key":"R24","doi-asserted-by":"publisher","first-page":"e1087","DOI":"10.1097\/SLA.0000000000005841","article-title":"Surgical outcomes in patients with low-risk papillary thyroid microcarcinoma from MAeSTro study: immediate operation versus delayed operation after active surveillance: a multicenter prospective cohort study","volume":"278","author":"Hwang","journal-title":"Ann Surg"},{"issue":"10","key":"R25","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.autrev.2020.102649","article-title":"Hashimoto\u2019s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation","volume":"19","author":"Ralli","journal-title":"Autoimmun Rev"},{"issue":"3","key":"R26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/ncpendmet0428","article-title":"A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid","volume":"3","author":"Ito","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"2","key":"R27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/thy.2020.0330","article-title":"Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery Task Force on management for papillary thyroid microcarcinoma","volume":"31","author":"Sugitani","journal-title":"Thyroid"},{"issue":"2","key":"R28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00268-022-06770-z","article-title":"Thyroid-stimulating hormone, age, and tumor size are risk factors for progression during active surveillance of low-risk papillary thyroid microcarcinoma in adults","volume":"47","author":"Ito","journal-title":"World J Surg"},{"issue":"S3","key":"R29","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1245\/s10434-015-4765-z","article-title":"Association between obesity and BRAFV600E mutation status in patients with papillary thyroid cancer","volume":"22","author":"Lee","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40463-017-0247-6","article-title":"Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis","volume":"47","author":"Kim","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"5","key":"R31","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s00268-019-05337-9","article-title":"The association between chronic lymphocytic thyroiditis and the progress of papillary thyroid cancer","volume":"44","author":"Lee","journal-title":"World J Surg"},{"issue":"4","key":"R32","doi-asserted-by":"publisher","first-page":"300060520919222","DOI":"10.1177\/0300060520919222","article-title":"Changes in Treg numbers and activity in papillary thyroid carcinoma with and without Hashimoto\u2019s thyroiditis","volume":"48","author":"Zhao","journal-title":"J Int Med Res"},{"issue":"1","key":"R33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-97969-2","article-title":"Role of prokineticins and T-reg cells in obesity-associated metabolic oxidative dysregulation in NAFLD","volume":"15","author":"Prakash","journal-title":"Sci Rep"},{"issue":"9","key":"R34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1530\/ERC-17-0085","article-title":"Hashimoto\u2019s thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer","volume":"24","author":"Marotta","journal-title":"Endocr Relat Cancer"}],"container-title":["JMIR Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cancer.jmir.org\/2026\/1\/e80535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:14:04Z","timestamp":1782843244000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancer.jmir.org\/2026\/1\/e80535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":34,"URL":"https:\/\/doi.org\/10.2196\/80535","relation":{},"ISSN":["2369-1999"],"issn-type":[{"value":"2369-1999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"article-number":"v12i6e80535"}}